Maternal nutritional status influences fetal development and long-term risk for adult 28 non-communicable diseases. The underlying mechanisms of these long-term effects remain 29 poorly understood. We examined whether maternal biomarkers for metabolism and 30 inflammation during pregnancy were associated with child biomarkers in the 31 Supplementation with Multiple Micronutrients Intervention Trial (SUMMIT, 32 ISRCTN34151616) in Lombok, Indonesia wherein archived blood specimens and relevant 33 data were available from pregnant women and their children 9-12 years after birth. Forty-four 34 mother-child dyads comprising 132 specimens were analyzed by multiplex microbead 35 immunoassays to quantify vitamin D-binding protein (D), adiponectin (A), retinol-binding 36 protein 4 (R), C-reactive protein (C), and leptin (L). Principal component analysis (PCA) 37 revealed distinct variance patterns, i.e. principal components (PC), for baseline pregnancy 38 bp.pc1.DAR and bp.pc2.CL; combined follow-up and post-partum dp-39 pp.pc1.DARL and dp-pp.pc2.ACL; and children ch.pc1.DRC and 40 ch.pc2.DAL. Maternal multiple micronutrient (MMN) supplementation modified the 41 association between baseline maternal bp.pc2.CL and post-supplementation maternal dp-42 pp.pc2.ACL (p=0.022). Significant associations were found between maternal dp-43 pp.pc2.ACL and increased child's ch.pc1.DRC (p=0.036), and decreased child's 44 BMI z-score (BMIZ) (p=0.022); and between maternal dp-pp.pc1.DARL and 45 increased child's BMIZ (p=0.036). Child's ch.pc1.DRC was associated with decreased 46 birth weight (p=0.036), and increased child's BMIZ (p=0.002); and ch.pc2.DAL was 47 associated with increased child's BMIZ (p=0.005), decreased maternal height (p=0.030) and
238 245 We analyzed the association between baseline maternal PC and maternal nutrition 246 status including maternal hemoglobin at baseline, maternal height, and maternal MUAC. We 247 found that maternal MUAC was significantly associated with baseline maternal PC1 248 bp.pc1.DAR ( = 0.019, p = 0.030) (Table 3) . Individual maternal biomarkers analysis 249 with maternal nutritional status is presented in S1 Table. 250 Table 4 . We found that the baseline 263 maternal PC2 bp.pc2.CL was significantly associated with the combined post-264 supplementation maternal PC1 dp-pp.pc1.DARL ( = 0.518, p = 0.022). The 265 baseline maternal PC1 bp.pc1.DAR was significantly associated with the post-266 supplementation maternal PC2 dp-pp.pc2.ACL ( = 0.315, p = 0.028) (Table 4) .
267 Furthermore, we tested the interaction between maternal PC at baseline and supplementation 268 type with maternal PC at post supplementation. We found that the interaction between MMN 269 supplementation and baseline maternal PC2 bp.pc2.CL was significantly associated with 270 post-supplementation maternal PC2 dp-pp.pc2.ACL (p = 0.022) ( Figure 3A) . Individual 271 analysis of maternal baseline and post-supplementation biomarkers is shown in S2 Table. 272 273 
293
Interaction plot between maternal PC2 dp-pp.pc2.ACL and child PC1 ch.pc1.DRC.
294
295 Association of maternal and child biomarkers 296 We found that the post-supplementation maternal PC2 dp-pp.pc2.ACL was significantly 297 associated with child PC1 ch.pc1.DRC ( = 0.439, p = 0.036) ( Figure 3B ). Birth weight 298 was also associated with child PC1 ch.pc1.DRC ( = -0.826, p = 0.036). And we 299 observed that maternal height ( = 0.097, p = 0.030), child's gender boys having lower 300 scores ( = 0.958, p = 0.002), and timing of post-supplementation during pregnancy, with 301 samples collected during pregnancy having higher scores ( = 1.224, p <0.001, power = 302 0.972) were significantly associated with child PC2 ch.pc2.DAL (Table 5 ). The 303 association of individual child biomarkers with maternal biomarkers at baseline and post-304 supplementation with child biomarkers are shown in S3 Table and S4 Table. 305 306 319 Association of child health outcome with maternal and child biomarkers 320 We then analyzed the association of maternal and child biomarker PC scores with child health outcomes (BMIZ, SBP and DBP) with (Table 6) . 321 We found maternal dp-pp.pc2.ACL was negatively associated with child BMIZ ( = -0.302, p = 0.022), and maternal dp-322 pp.pc1.DARL ( = 0.224, p = 0.036), ch.pc1.DRC ( = 0.347, p = 0.002) and ch.pc2.DAL( = 0.515, p = 0.005) were 323 positively associated with child BMIZ (Figrue 4). Baseline maternal Hb ( = -0.280, p = 0.010), maternal MUAC ( = 0.014, p = 0.027), and 324 timing of post-supplementation sampling ( = -1.064, p = 0.005, power = 0.972) also showed significant association with child BMIZ. No 325 significant associations were found with child SBP and DBP. The association of child health outcome with maternal biomarkers and child 326 biomarkers are shown in S5 
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Despite the sparsity of the data, which is the limitation of this study, the consistency of 422 the associations observed is of interest. Nevertheless, replication of this study's findings 423 would be warranted. In addition, due the multiple hypotheses tested, the multiple 424 comparisons in the study were unavoidable, but again we note the consistency of the findings.
425 To our knowledge, this is the first study with complete mother-child dyads showing the effect 426 of MMN on the child outcomes via changes of the mother's biomarkers. As with other effect 427 of nutrients, the MMN effect cannot be determined based on a single biomarker only, as there 428 would be many pathways involved. Therefore, analyzing the effect of a particular pattern of 429 combined relevant biomarkers is more relevant, as conducted here.
430
In conclusion, maternal biomarkers of adipocytokines and inflammatory markers PC 431 during pregnancy were modulated by MMN supplementation, and associated with child PC 432 scores of the same biomarkers 9-12 years later, as well as with children's BMIZ. Improving
